Skip to main content
. 2021 May 2;68(3):298–309. doi: 10.1002/jmrs.469
Organ at risk Dose constraint Maximum limit
50 Gy/5F 48 Gy/4F
Bronchus and trachea Max (Gy) <52.5 <50.4
V15.6 Gy (mL) <4
V18 Gy (mL) <4
V32 Gy (mL) <1
Lungs‐GTV Mean (Gy) <4 <4
V20 Gy (mL) <8% <8%
Heart Max (Gy) <52.5 <50.4
V27 Gy (mL) <1
V32 Gy (mL) <15
Brachial plexus Max (Gy) <32 <32
V23.6 Gy (mL) <3
V30 Gy (mL) <3
Oesophagus Max (Gy) <52.5 <50.5
V18.8 Gy (mL) <5
V27.5 Gy (mL) <5 <1
Chest wall V30 Gy (mL) <30 <30
Spinal cord Max (Gy) <28 <28
V13.5 Gy (mL) < 0.5 <1.2
V20.8 Gy (mL) <0.35
V22.5 Gy (mL) <0.25
Vertebrate Max (Gy) <54 <54
Great vessels Max (Gy) <52.5 <45
V39 Gy (mL) <10
V47 Gy (mL) <10
Skin Max (Gy) <32 <32
V24 Gy (mL) <10 <10
Ribs Max (Gy) <52.5 <50.4

Dn cc dose received by a volume of n cc; GTV, gross tumour volume; Max, maximum dose; V 50%, volume receiving 50% of prescription dose; Vn Gy, volume receiving a dose of n Gy.